Literature DB >> 22154434

Association of bone mineral density, parameters of bone turnover, and body composition in patients with chronic obstructive pulmonary disease.

Georgios A Fountoulis1, Markos Minas, Panagiotis Georgoulias, Ioannis V Fezoulidis, Konstantinos I Gourgoulianis, Marianna Vlychou.   

Abstract

Patients with chronic obstructive pulmonary disease (COPD) often develop osteoporosis. Many hormones regulate bone metabolism and body composition, and some of them are affected in COPD patients vs controls. In 46 COPD patients, we measured hip neck, total hip, lumbar spine, and whole-body T-score with dual-energy X-ray absorptiometry, parameters of body composition (body mass index [BMI], fat mass index [FMI], and fat-free mass index [FFMI]), and adiponectin, leptin, parathormone, osteocalcin, calcitonin, and insulin-like growth factor I (IGF-I) serum levels and correlated them with COPD stage. Our results suggest that total hip bone mineral density (BMD) is affected by FFMI and COPD stage; lumbar spine BMD is affected by FMI and COPD stage; and whole-body BMD is affected by BMI, COPD stage, and leptin. Adiponectin, parathormone, osteocalcin, calcitonin, and IGF-I levels were not significantly correlated to BMD at any of the measured sites. Our findings are in agreement with the current literature in that a decline in lung function is correlated to a decline in BMD.
Copyright © 2012 The International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22154434     DOI: 10.1016/j.jocd.2011.10.004

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.617


  2 in total

1.  Analytic Morphomics Predict Outcomes After Lung Transplantation.

Authors:  Michael J Pienta; Peng Zhang; Brian A Derstine; Binu Enchakalody; William B Weir; Tyler Grenda; Rebecca Goulson; Rishindra M Reddy; Andrew C Chang; Stewart C Wang; Jules Lin
Journal:  Ann Thorac Surg       Date:  2017-12-02       Impact factor: 4.330

2.  Role of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand in Bone Loss Related to Advanced Chronic Obstructive Pulmonary Disease.

Authors:  Ludmila Ugay; Evgenia Kochetkova; Vera Nevzorova; Yuliya Maistrovskaia
Journal:  Chin Med J (Engl)       Date:  2016-07-20       Impact factor: 2.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.